Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  582 results for ""CD40 Ligand""

Your Filters

Subject : cardiovascular diseases
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients.

  • Authors : Falasca K; Clinic of Infectious Diseases, Department of Medicine and Science of Aging, University 'G. d'Annunzio' Chieti-Pescara, Chieti, Italy.; Reale M

Subjects: CD40 Ligand/CD40 Ligand/CD40 Ligand/*blood ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*blood ; HIV Infections/HIV Infections/HIV Infections/*blood

  • Source: HIV medicine [HIV Med] 2019 Nov; Vol. 20 (10), pp. 681-690. Date of Electronic Publication: 2019 Aug 19.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Read Online Read More Add to Saved list
×
Editorial & Opinion

sCD40L: An overestimated marker for cardiovascular risk prediction?

  • Authors : Pesau G; Division of Angiology, Department of Medicine II, Medical University of Vienna, Austria.; Schernthaner GH

Subjects: CD40 Ligand* ; Cardiovascular Diseases*; Biomarkers

  • Source: Atherosclerosis [Atherosclerosis] 2019 Dec; Vol. 291, pp. 122-123. Date of Electronic Publication: 2019 Oct 16.Publisher: Elsevier Country of Publication: Ireland NLM ID: 0242543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1484

Record details

Read More Add to Saved list
×
Academic Journal

Soluble CD40 ligand in haemodialysis patients: survival impact and cardiovascular prognostic role.

  • Authors : Rusu C; a Department of Nephrology , University of Medicine and Pharmacy 'Iuliu Hatieganu', Cluj-Napoca , Romania.; Racasan S

Subjects: CD40 Ligand/CD40 Ligand/CD40 Ligand/*blood ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*etiology ; Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/*diagnosis

  • Source: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals [Biomarkers] 2017 May - Jun; Vol. 22 (3-4), pp. 232-238. Date of Electronic Publication: Publisher: Tayor & Francis Country of Publication: England NLM ID: 9606000 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease.

  • Authors : Bosmans LA; Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.; Bosch L

Subjects: CD40 Antigens/CD40 Antigens/CD40 Antigens/*immunology ; CD40 Ligand/CD40 Ligand/CD40 Ligand/*immunology ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*etiology

  • Source: Journal of cardiovascular translational research [J Cardiovasc Transl Res] 2021 Feb; Vol. 14 (1), pp. 13-22. Date of Electronic Publication: 2020 Mar 28.Publisher: Springer Country of Publication: United States NLM ID: 101468585 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease-The Pros and Cons for Cardioprotection.

  • Authors : Daub S; Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.; Lutgens E

Subjects: Signal Transduction*; CD40 Antigens/CD40 Antigens/CD40 Antigens/*metabolism ; CD40 Ligand/CD40 Ligand/CD40 Ligand/*metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2020 Nov 12; Vol. 21 (22). Date of Electronic Publication: 2020 Nov 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read More Add to Saved list
×
Academic Journal

Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization.

  • Authors : Gremmel T; Center for Platelet Research Studies, Division of Hematology/Oncology, Boston Children´s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America; Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Subjects: Cardiac Catheterization*; Aspirin/Aspirin/Aspirin/*therapeutic use ; CD40 Ligand/CD40 Ligand/CD40 Ligand/*blood

  • Source: PloS one [PLoS One] 2015 Aug 03; Vol. 10 (8), pp. e0134599. Date of Electronic Publication: 2015 Aug 03 (Print Publication: 2015).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Editorial & Opinion

Light-dark patterns of soluble CD40 ligand: clinical implications.

Subjects: CD40 Ligand/CD40 Ligand/CD40 Ligand/*genetics ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*blood; Animals

  • Source: American heart journal [Am Heart J] 2009 Feb; Vol. 157 (2), pp. e3. Date of Electronic Publication: 2008 Dec 23.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744

Record details

Read More Add to Saved list
×
Academic Journal

[Soluble CD40 ligand: a potential marker of cardiovascular risk].

Subjects: CD40 Ligand*/CD40 Ligand*/CD40 Ligand*/blood ; CD40 Ligand*/CD40 Ligand*/CD40 Ligand*/genetics; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*epidemiology

  • Source: Revista clinica espanola [Rev Clin Esp] 2007 Sep; Vol. 207 (8), pp. 418-21.Publisher: Elsevier España Country of Publication: Spain NLM ID: 8608576 Publication Model: Print Cited Medium: Print ISSN: 0014-2565 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

CD40 ligand: a novel target in the fight against cardiovascular disease.

Subjects: CD40 Ligand/CD40 Ligand/CD40 Ligand/*blood ; Cardiovascular Agents/Cardiovascular Agents/Cardiovascular Agents/*therapeutic use ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*blood

  • Source: The Annals of pharmacotherapy [Ann Pharmacother] 2004 Sep; Vol. 38 (9), pp. 1500-8. Date of Electronic Publication: 2004 Jul 27.Publisher: Sage Country of Publication: United States NLM ID: 9203131 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1060-0280

Record details

Read More Add to Saved list
×
Academic Journal

Association of soluble CD40L with short-term and long-term cardiovascular and all-cause mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.

  • Authors : Gergei I; 5th Medical Department, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Germany.; Kälsch T

Subjects: CD40 Ligand/CD40 Ligand/CD40 Ligand/*blood ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*blood ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*mortality

  • Source: Atherosclerosis [Atherosclerosis] 2019 Dec; Vol. 291, pp. 127-131. Date of Electronic Publication: 2019 Sep 14.Publisher: Elsevier Country of Publication: Ireland NLM ID: 0242543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1484

Record details

Read More Add to Saved list
×
  • 1-10 of  582 results for ""CD40 Ligand""